Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business &...
internet stock review

Innovus (INNV) Conference Call Transcript.

Q1 2019 Results, 5/15/19.  Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM...

Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate Update.

Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in...
internet stock review

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial...
biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.”...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.

3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.

Chronic wounds represent a large and growing threat to public health. In the US alone, they affect over 6.5 million people. As...

Latest article

Zomedica Corp (ZOMDF) $0.05

Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...